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Abstract 
 
Aims: Previous research suggests that patients undergoing upper gastrointestinal surgery are at high 
risk of poor postoperative outcomes. The aim of our study was to describe patient outcomes after 
elective upper gastrointestinal surgery at a global level.  
 
Methods: Prospective analysis of data collected during an international seven-day cohort study of 
474 hospitals in 27 countries. Patients undergoing elective upper gastrointestinal surgery were 
recruited. Outcome measures were in-hospital complications and mortality at 30-days. Results are 
presented as n(%) and odds ratios with 95% confidence intervals. 
 
Results: 2139 patients were included, of whom 498 (23.2%) developed one or more postoperative 
complications, with 30 deaths (1.4%). Patients with complications had longer median hospital stay 
11 (6-18) days vs. 5 (2-10) days. Infectious complications were most frequent, affecting 368 (17.2%) 
patients. 328 (15.3%) patients were admitted to critical care postoperatively, of whom 161 (49.1%) 
developed a complication with 14 deaths (4.3%). In a multivariable logistic regression model we 
identified age (OR 1.02 [1.01-1.03]), American Society of Anesthesiologists physical status III (OR 
2.12 [1.44-3.16]) and IV (OR 3.23 [1.72-6.09]), surgery for cancer (OR 1.63 [1.27-2.11]), open 
procedure (OR 1.40 [1.10-1.78]), intermediate surgery (OR 1.75 [1.12-2.81]) and major surgery (OR 
2.65 [1.72-4.23]) as independent risk factors for postoperative complications. Patients undergoing 
major surgery for upper gastrointestinal cancer experienced twice the rate of complications 
compared to those undergoing other procedures (224/578 patients [38.8%] versus 274/1561 
patients [17.6%]). 
 
Conclusions: Complications and death are common after upper gastrointestinal surgery. Patients 
undergoing major surgery for cancer are at greatest risk.  
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Introduction 
Currently, 310 million patients undergo surgery worldwide each year, with more procedures taking 
place in high-income countries.[1,2] Estimates of mortality following in-patient surgery vary from 1 
to 4%,[3-10] but it is now recognised that selected high-risk patient groups are more likely to 
develop life threatening complications. Postoperative complications increase treatment 
costs,[11,12] and reduce both life expectancy and quality of life at a societal level.[3,14] Whilst 
technical errors are unusual during surgery and anaesthesia, poor patient outcomes persist for a 
variety of reasons. Improvements in the quality of perioperative care for high-risk patients may 
therefore lead to better patient outcomes.  
 
Patients undergoing surgery to treat cancer of the upper gastrointestinal tract are an important 
high-risk group. This includes cancers of the oesophagus, and stomach, which have a poor long-term 
prognosis. Worldwide, oesophageal cancer is the sixth leading cause of death from cancer.[15] 
Surgical resection remains the only potentially curative treatment, and is integrated in a multimodal 
therapy, particularly for advanced disease. Recent data from the United Kingdom suggest one third 
of patients undergoing oesophageal and gastric surgery for cancer, experience postoperative 
complications, with hospital mortality rates in the region of 3%.[16] Other reports describe 
complication rates between 40 and 80%, depending on age, gender, type of surgery, and the 
presence of chronic disease.[17,18] 
 
The need remains to better understand patient outcomes following upper gastrointestinal surgery, 
to ensure the planning of effective perioperative care, including appropriate patient selection, 
surgical approach and postoperative provision of critical care.[14] The International Surgical 
Outcomes Study (ISOS) was recently conducted to evaluate the incidence and risk factors for 
complications and death after in-patient elective surgery at a global level, and to describe current 
standards of postoperative care.[19] ISOS included a prospective sub-group analysis to describe in 
detail, the clinical outcomes and standards of perioperative care following upper gastrointestinal 
surgery at a global level, and to describe factors associated with complications during the hospital 
stay and death in this population.  
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Patients and Methods 
Project organisation 
ISOS was approved by the Yorkshire & Humber Research Ethics Committee (Reference: 13/YH/0371). 
We then conducted a sub-group analysis of data collected during this international seven-day cohort 
study of outcomes following elective adult in-patient surgery. Regulatory requirements differed 
between countries with some requiring research ethics approval and some requiring only data 
governance approval. Each participating country selected a single data collection week between 
April and August 2014. Patient data included only that recorded as part of routine care. Local 
investigators were supported by national co-ordinators, the international study management group, 
and via a website which provided all study documentation and guidance on study procedures 
(www.isos.org.uk/documents). The main ISOS project was registered prospectively with an 
international trial registry (ISRCTN51817007). The manuscript has been prepared according to the 
STROBE statement.[20] 
 
The inclusion criteria were all adult patients (age ≥18 years) undergoing elective surgery with a 
planned overnight stay in hospital. Patients undergoing emergency surgery, day-case surgery or 
radiological procedures were excluded. We aimed to recruit as many hospitals and countries as 
possible and asked investigators in those hospitals to enrol all eligible patients. No formal sample 
size calculation was performed. Only hospitals returning valid data describing ≥20 patients and 
countries with ≥10 participating hospitals were included in the primary analysis of the ISOS 
dataset.[19] In this sub-group analysis, we included all patients who underwent upper 
gastrointestinal surgery by the thoracic or abdominal route, using either an open or laparoscopic 
technique, identified via the e-CRF.[19] We also investigated whether there were any differences in 
outcomes between high-income countries, and low or middle-income countries. 
 
Data collection 
Data describing consecutive patients were collected until hospital discharge on paper case record 
forms. Data were censored at 30 days following surgery for patients who remained in hospital. Data 
were anonymised before entry onto a secure internet-based electronic case record form designed 
specifically for ISOS, which incorporated automated checks for plausibility, consistency and 
completeness. 
 
Outcome measures 
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The primary outcome measure was in-hospital postoperative complications assessed using 
predefined criteria and graded according to the Clavien-Dindo classification.[21,22] The secondary 
outcome measure was in-hospital mortality. Process measures were admission directly to critical 
care after surgery, admission to critical care for treatment of a postoperative complication, and 
duration of hospital stay. A single prospective definition of critical care was used for all countries (a 
facility routinely capable of admitting patients who require invasive ventilation overnight). 
 
Statistical analysis 
Statistical analysis was performed using SPSS (version 20.0) and R: A language and environment for 
statistical computing (R Foundation for Statistical Computing, Vienna, Austria). Categorical variables 
are presented as number (%) and continuous variables as mean (SD) where normally distributed and 
median (IQR) where not normally distributed. Univariable analysis was used to select risk factors for 
postoperative complications. Multivariable logistic regression analysis was used to develop a generic 
model in which all previously determined risk factors were entered. The threshold for inclusion of 
variables in the multivariable analysis was p<0.05. All predictors were entered into the model using 
forced simultaneous entry. With the expected sample size, a limited number of factors could be 
included in the model without over fitting, and these were selected based on clinical suitability and 
assessment of correlated variables. Bootstrapping was used to assess the reliability of the models. 
Goodness-of-fit tests were performed using the Hosmer-Lemeshow test. A process of forward and 
backward selection, based on minimisation of Akaike’s Information Criterion (AIC), was used to 
derive the final model.[23] Results are presented as odds ratios with 95% confidence intervals. For 
variables included in our final model, univariable logistic regression was then performed to generate 
unadjusted odd ratios for comparison with the multivariable model. In the main ISOS database, data 
describing baseline risk factors were missing for a very small proportion of patients [451/44 814 
(1%)]. Due to the low proportion of missing data, we performed a complete case analysis where 
patients with missing data were excluded from the analysis.[19]  
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Results 
Data describing 44 814 patients were collected in 474 hospitals in the following countries and 
regions: Australia, Austria, Belgium, Brazil, Canada, China, Denmark, France, Germany, Greece, Hong 
Kong, Indonesia, Italy, Malaysia, Netherlands, New Zealand, Nigeria, Portugal, Romania, Russia, 
South Africa, Spain, Sweden, Switzerland, Uganda, United Kingdom, and the United States of 
America. Fewer than ten hospitals participated in India, Iraq and Mexico and in accordance with the 
prospective statistical analysis plan, patients recruited in these countries were excluded from the 
primary analysis. 2139 patients who underwent upper gastro-intestinal surgery in 369 centres were 
identified in the ISOS database (4 [2-7] patients per centre; Figure 1). Baseline patient data are 
presented in Table 1. 
 
Process measures 
The median stay in a post-anaesthetic care unit was 2 (1-3) hours. 328 (15.3%) patients were 
admitted to a critical care unit as routine immediately after surgery, with a median critical care stay 
of 1 (1-4) days. Of these patients, 161 (49.1%) developed a complication with 14 (4.3%) deaths. 121 
patients were admitted to a critical care unit to treat complications, of whom 17 (14%) died. The 
median duration of critical care stay for patients admitted to treat a complication was 5 (1-10) days. 
The median overall hospital stay was 5 (2-10) days, increasing to 11 (6-18) days amongst those 
patients who developed complications.  
 
Clinical outcomes 
In total, 498 (23.2%) patients developed complications in hospital, and 30 died before hospital 
discharge (1.4%). 297 (13.9%) patients developed a single postoperative complication whilst 201 
(9.4%) patients developed two or more complications. Data describing postoperative complications 
are presented in Table 2. There were 368 infectious complications affecting 254 patients, the most 
frequent being pneumonia and superficial surgical site infections of varying severity (Table 2). There 
were 125 complications affecting 97 patients related to technical aspects of surgery, such as 
postoperative bleeding and anastomotic leak (Table 2). The “All other” category of complications 
were not specified and included deep vein thrombosis, ileus, pancreatitis etc. Nine patients 
experiencing complications in this category died, however, all had additionally experienced 
infectious, cardiovascular, or other complications related to the technical aspects of the procedure. 
In the initial univariable regression analysis, age (OR 1.03 [1.02-1.04]), American Society of 
Anesthesiologists (ASA) physical status score III (OR 3.33 [2.32-4.78]) or IV (OR 5.51 [3.07-9.88]), 
surgery for cancer (OR 2.60 [2.11-3.21]), non-laparoscopic surgery (OR 1.79 [1.45-2.21]), 
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intermediate surgery (OR 1.81 [1.19-2.75]), major surgery (OR 4.34 [2.91-6.48]) and cirrhosis (OR 
2.28 [1.05-4.95]) were identified as risk factors for postoperative complications. However during the 
multivariable logistic regression analysis when adjusted for cofounders, only age, ASA status, surgery 
for cancer, non-laparoscopic surgery, intermediate and major surgery were identified as 
independent risk factors for postoperative complications (Table 3). This indicated major upper 
gastrointestinal surgery to treat cancer as a sub-population at particular risk of poor outcomes 
(Supplementary Table 1), with twice the rate of complications (224/578 major cancer patients 
[38.8%] versus 274/1561 [17.6%] patients undergoing minor, intermediate, or major non-cancer 
procedures (Figure 2). In the major cancer surgery group, 122 (21.1%) patients developed one 
complication, whilst 102 (17.6%) patients developed two or more complications during their 
postoperative stay in hospital. Of 2139 patients who underwent upper gastrointestinal surgery, 30 
died (1.4%). Non-survivors were older, had higher ASA scores and underwent major surgery 
(Supplementary Table 2).  
 
Comparison of high-income and low or middle-income countries: 
Using the World Bank classification, eight were classed as low or middle-income countries (Brazil, 
China, Indonesia, Malaysia, Nigeria, Romania, South Africa, and Uganda), and 19 were classed as 
high-income countries (Australia, Austria, Belgium, Canada, Denmark, France, Germany, Greece, 
Hong Kong, Italy, Netherlands, New Zealand, Portugal, Russia, Spain, Sweden, Switzerland, United 
Kingdom, and the United States of America).[24] Patient outcomes for major cancer surgery in high-
income countries were similar to the overall international sub-group with 326/1270 patients (25.7%) 
developing complications with six deaths (2.3%). In this post-hoc analysis, complication rates were 
lower in the low or middle-income countries 172/869 (19.8%) p<0.001. When explored this we 
found that although age was similar in both the high and low or middle-income countries 57 (44-68) 
vs 58 (46-66) years, ASA distribution significantly differed with more ASA 2, 3 and 4 patients being 
operated in the high income countries (Supplementary Figure 1). Patients in high-income countries 
underwent fewer minor procedures (Supplementary Figure 2). There were no significant differences 
between high or low and middle-income countries in terms of risk of complications in the 
univariable analysis.  
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Discussion 
We report data from an international prospective cohort study describing detailed postoperative 
outcomes for a population of more than 2,000 patients undergoing elective upper gastrointestinal 
surgery in 27 countries worldwide. The principal findings were that one in four patients experienced 
a complication before hospital discharge, compared to one in six of the overall surgical population in 
the parent study.[19] Surgery involving the upper gastrointestinal tract was associated with higher 
risk of complications compared to the reference category of orthopaedic surgery in the complete 
ISOS dataset.[19] According to our results, complications in the upper gastrointestinal surgery group 
were associated with a two-fold increase in hospital stay, and one in fifteen patients who developed 
a complication died before hospital discharge. Patients undergoing major cancer surgery are at 
particular risk, with twice the postoperative complication rate of other patients undergoing upper 
gastrointestinal surgery. In the univariable analysis, risk of complication was similar when high-
income countries were compared to low and middle-income countries. Our results suggest that the 
greater crude complication rates in high-income countries largely relate to differences in casemix. 
This finding suggests that measures to reduce complication rates remain important in all countries, 
regardless of income status.  
 
The complication rates observed in this analysis are lower than those reported in recently studies 
from Sweden, Japan, Australia and the UK.[16,25-27] The Australian, Japanese and UK studies all 
reported complications during hospital stay, similar to our methods. Unlike our contemporary 
snapshot of practice, these studies collected information on patients over several years.[25-27] The 
ongoing change and improvement in clinical practice over the last decade might partly account for 
the lower observed complication rates in our series.[28] Infectious complications such as surgical 
site infections and pneumonia remain commonplace, and are associated with prolonged hospital 
stays. In previous studies, pneumonia rates as high as 22.5% were reported following 
oesophagectomy, whereas in our series the rate was only 4.0%, even in the major cancer surgery 
sub-group.[16,25-27]  Similarly, technical complications of surgery were less frequent in this dataset, 
although this may relate to differences in casemix and improvements in surgical technique and 
perioperative care compared to the standards observed in previous studies in this international 
patient sample. [16,25-27]   
Mortality rates were lower than expected given the observed complication rates. It is possible that 
this relates to improvements in the care of patients who develop complications, although this may 
also be affected by the duration of critical care stay for patients who develop life threatening 
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complications after major elective surgery, which may now routinely exceed 30 days before 
treatment is withdrawn for reasons of futility. In this context, 30-day mortality may not truly reflect 
the seriousness of eventual patient outcomes. The risk factors for postoperative complications 
identified in the ISOS study are well recognised. Age has been shown to be independently associated 
with higher post-operative morbidity and mortality after major upper gastrointestinal 
procedures,[29-31] although age alone should not be viewed as a reason to deny patients a 
definitive surgical treatment. A recent Australian study did not demonstrate any correlation 
between age and long-term survival, even though postoperative complications were more frequent 
amongst elderly patients.[31] The findings from our larger international study are consistent with 
this previous work, confirming the high incidence of complications early after upper gastrointestinal 
surgery amongst elderly patients. ASA score has been highlighted as a strong predictor of 
postoperative complications.[32] It is interesting to note that a relatively large proportion of patients 
undergoing upper gastrointestinal surgery were classed as ASA III or IV, in both cancer and non-
cancer cancer groups, with a corresponding increase in the frequency of complications. Similar 
findings have recently been reported in the UK, with one third of patients undergoing 
oesophagectomy falling into ASA III and IV categories.[33] Recent recommendations for the 
treatment of upper gastrointestinal cancer recommend careful patient selection based on 
physiological reserve and pre-existing co-morbid disease.[34,35] One in six patients in this cohort 
were admitted to a critical care unit immediately after surgery, half of whom experienced 
postoperative complications. Although significant progress has been made in the development of 
perioperative pathways to improve patient outcomes, it remains uncertain what the most 
appropriate level of postoperative care should be for this high-risk patient group. This is highlighted 
in the findings of a recent analysis of a large US dataset, which did not identify any benefit of routine 
critical care admission immediately after major upper gastrointestinal cancer surgery.[36] The 
secondary analysis of the ISOS dataset also failed to signal any mortality benefit of routine critical 
care admission following high-risk elective surgery.[37] 
The strengths of this study have been discussed in detail in our previous publication.[19] We used a 
very simple data set consisting primarily of categorical variables to aid data collection and 
minimising empty data fields. Patient-level variables were selected on the basis that they were 
objective, and routinely available to local investigators. We carefully defined surgical procedure 
categories to identify patients undergoing major upper gastrointestinal surgery by either the 
abdominal or thoracic route. We also asked investigators to confirm whether the indication for 
surgery was cancer. The study also has a number of weaknesses. The ISOS project was prospectively 
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designed to allow us to clearly identify patients undergoing upper gastrointestinal surgery, but its’ 
main objective was to evaluate all elective in-patient surgery. Baseline data were not specific to the 
upper gastrointestinal surgical procedure category, and our multivariable model may not fully 
account for high mortality rates in hospitals specialising in more complex surgery due to the low 
number of patients recruited in each centre. It is possible, that given the pragmatic nature of ISOS 
study looking at only complications during the hospital stay, we missed some of the later events, 
possibly resulting in an under-estimate of the incidence of postoperative complications. Also, due to 
the pragmatic nature of the study, external verification of the imputed data was not possible, 
potentially resulting in misreporting of complications. However, the similar studies from different 
countries also limited their data collection period to in-hospital stay or 30 days postoperatively and 
suffered from lack of external data verification.[16,25-28]  
 
Conclusions 
The findings of this international cohort study indicate that a large number of patients develop 
complications after elective in-patient upper gastrointestinal surgery. Patients undergoing major 
cancer surgery were at particular risk with complication rates approaching one in two patients.  To 
improve patient outcomes, the concept of perioperative medicine is being adopted more widely to 
ensure safe and effective patient care throughout the perioperative care pathway.[39] International 
datasets help to set out the baseline for further quality improvement initiatives and can be used for 
perioperative decision-making and informed consent during upper gastrointestinal surgery. 
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